Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine as Add-on Therapy in PTSD
NCT00306540Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2004
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Placebo + Existing Therapy with Quetiapine + Existing Therapy (2 arms). Primary endpoint: Clinical Administered PTSD Scale. Started Dec 2004; status: completed.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00306540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306540.